C Difficile Vaccine Shows Lot Consistency, Induces Toxin A and B Antibody Responses

Data from the phase 3 study confirmed the lot consistency, immunogenicity, safety, and tolerability of a toxoid-based Clostridioides difficile vaccine.

Related Keywords

Shane Christensen , ,Clostridioides Difficile Vaccine ,C Difficile ,C Diff ,Ccdi ,Infectious Disease ,